A View from Erika Jonietz

Stem Cell Sales Tactics

Commenting on California’s Prop 71 to fund stem cell research, my blogging colleague David Appell makes an excellent point about stem cells and Alzheimer’s, but he may be overstating the case a bit. An increasingly frequent–and legitimate–criticism of proponents of…

  • September 20, 2004

Commenting on California’s Prop 71 to fund stem cell research, my blogging colleague David Appell makes an excellent point about stem cells and Alzheimer’s, but he may be overstating the case a bit. An increasingly frequent–and legitimate–criticism of proponents of embryonic stem cell research is their tendency to link the cells with a treatment for Alzheimer’s (and tie such research to a legacy for President Reagan). However, as researchers point out, even if stem cells do not pan out as a therapy for Alzheimer’s, studies using the cells will still help patients by increasing our understanding of the disease. Such research could even lead to a new drug or other treatment that doesn’t use ES cells.

Singling out the tenuous Alzheimer’s link as a tactic being used to “sell” California voters on stem cells strikes me as a bit disingenuous. As David notes, there are at least 70 diseases, many of them common, such as diabetes and heart disease, that might be treated with stem cells. And there are countless others, such as Alzheimer’s and almost any form of cancer, that could be better understood through research using embryonic stem cells (as well as adult stem cells). It is indeed better to be up front with voters–about both the limits and the incredible potential of research on all types of stem cells.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

    Access to the Magazine archive. Over 24,000 articles going back to 1899 at your fingertips.

    Special Discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look. Exclusive early access to stories.

    Insider Conversations. Listen in as our editors talk to innovators from around the world.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.